designed and developed SIAIS164018 (Figure 28), a PROTAC capable of degrading ALKG1202R mutant and EGFRL858R/T790M mutations, both key ALK fusion proteins in NSCLC. This evidence concerns the gene ALK and non-small cell lung carcinoma.